CAMP and neoplasm: Accumulating studies have revealed that hCAP18/LL-37 plays a role in the promotion of tumor growth in several types of tumors through direct stimulation of malignant cells, initiation of angiogenesis or suppressing immunity in the tumor microenvironment [8,9].